Clinical Trial Update: Carmat TAH Early Feasibility Study [NA]

View source ↗

Summary

Carmat's Total Artificial Heart early feasibility study has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Heart Failure

Drugs mentioned

• Carmat Total Artificial Heart (TAH)

Snippet

Sponsor: Carmat SAS | Conditions: End-stage Heart Failure | NA | Status: SUSPENDED